⌘K

BioAtla, Inc. (BCAB)

$1.74 4.82% $0.08 Healthcare

BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, melanoma, and ovarian cancer; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California.

Market cap

$84.10M

CEO

Dr. Jay M. Short Ph.D.

Full time employees

56.00

Headquarters

San Diego, CA

IPO Date

Dec 16, 2020

Price-to-earnings (PE) Ratio

-0.80

Earnings-per-share (EPS)

$-2.17

Cash ratio (TTM)

3.53

Current ratio (TTM)

3.81

Net profit margin (TTM)

-6,128.72%

PE ratio (TTM)

-0.77

PEG ratio (TTM)

0.04

Price-to-book ratio (TTM)

2.58

Price-to-sales ratio (TTM)

47.60

Quick ratio (TTM)

3.81

Return on assets (TTM)

-152.33%

Return on equity (TTM)

-169.69%

Similar stocks (18)

Kymera Therapeutics, Inc.

KYMR

$49.03 5.58% $2.59

Uptrend

Nurix Therapeutics, Inc.

NRIX

$25.06 1.29% $0.32

Uptrend

Erasca, Inc.

ERAS

$2.97 2.77% $0.08

Uptrend

Olema Pharmaceuticals, Inc.

OLMA

$13.60 6.17% $0.79

Neutral

Foghorn Therapeutics Inc.

FHTX

$9.67 1.15% $0.11

Uptrend

C4 Therapeutics, Inc.

CCCC

$6.57 2.98% $0.19

Neutral

Monte Rosa Therapeutics, Inc.

GLUE

$6.25 5.04% $0.30

Neutral

Nautilus Biotechnology, Inc.

NAUT

$3.00 4.53% $0.13

Neutral

Design Therapeutics, Inc.

DSGN

$5.86 3.90% $0.22

Uptrend

Rezolute, Inc.

RZLT

$4.82 -1.03% $-0.05

Uptrend

Acrivon Therapeutics, Inc. Common Stock

ACRV

$7.59 0.40% $0.03

Neutral

Shattuck Labs, Inc.

STTK

$3.70 1.37% $0.05

Downtrend

Century Therapeutics, Inc.

IPSC

$1.70 3.03% $0.05

Downtrend

Ikena Oncology, Inc.

IKNA

$1.71 3.01% $0.05

Neutral

PMV Pharmaceuticals, Inc.

PMVP

$1.52 0.66% $0.01

Downtrend

Aerovate Therapeutics, Inc.

AVTE

$1.98 3.66% $0.07

Downtrend

Passage Bio, Inc.

PASG

$0.70 -0.14% $-0.00

Downtrend

AN2 Therapeutics, Inc.

ANTX

$1.08 1.89% $0.02

Downtrend

ETF Exposure (13)

iShares Micro-Cap ETF

IWC

0.02128%

$126.54 2.19% $2.71

Uptrend

Dimensional U.S. Small Cap ETF

DFAS

7.815900000000001e-4%

$65.11 2.13% $1.36

Uptrend

Dimensional U.S. Targeted Value ETF

DFAT

6.073599999999999e-4%

$55.91 2.01% $1.10

Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

$49.43 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

$49.42 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund

VBINX

$49.42 -0.26% $-0.13

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$96.13 -0.25% $-0.24

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$96.11 -0.25% $-0.24

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.99 -0.24% $-0.33

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$282.05 1.69% $4.70

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.97 -0.24% $-0.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.92 2.00% $3.58

Uptrend

Downtrend

Similar stocks (18)

Kymera Therapeutics, Inc.

KYMR

$49.03 5.58% $2.59

Uptrend

Nurix Therapeutics, Inc.

NRIX

$25.06 1.29% $0.32

Uptrend

Erasca, Inc.

ERAS

$2.97 2.77% $0.08

Uptrend

Olema Pharmaceuticals, Inc.

OLMA

$13.60 6.17% $0.79

Neutral

Foghorn Therapeutics Inc.

FHTX

$9.67 1.15% $0.11

Uptrend

C4 Therapeutics, Inc.

CCCC

$6.57 2.98% $0.19

Neutral

Monte Rosa Therapeutics, Inc.

GLUE

$6.25 5.04% $0.30

Neutral

Nautilus Biotechnology, Inc.

NAUT

$3.00 4.53% $0.13

Neutral

Design Therapeutics, Inc.

DSGN

$5.86 3.90% $0.22

Uptrend

Rezolute, Inc.

RZLT

$4.82 -1.03% $-0.05

Uptrend

Acrivon Therapeutics, Inc. Common Stock

ACRV

$7.59 0.40% $0.03

Neutral

Shattuck Labs, Inc.

STTK

$3.70 1.37% $0.05

Downtrend

Century Therapeutics, Inc.

IPSC

$1.70 3.03% $0.05

Downtrend

Ikena Oncology, Inc.

IKNA

$1.71 3.01% $0.05

Neutral

PMV Pharmaceuticals, Inc.

PMVP

$1.52 0.66% $0.01

Downtrend

Aerovate Therapeutics, Inc.

AVTE

$1.98 3.66% $0.07

Downtrend

Passage Bio, Inc.

PASG

$0.70 -0.14% $-0.00

Downtrend

AN2 Therapeutics, Inc.

ANTX

$1.08 1.89% $0.02

Downtrend

ETF Exposure (13)

iShares Micro-Cap ETF

IWC

0.02128%

$126.54 2.19% $2.71

Uptrend

Dimensional U.S. Small Cap ETF

DFAS

7.815900000000001e-4%

$65.11 2.13% $1.36

Uptrend

Dimensional U.S. Targeted Value ETF

DFAT

6.073599999999999e-4%

$55.91 2.01% $1.10

Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

$49.43 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

$49.42 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund

VBINX

$49.42 -0.26% $-0.13

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$96.13 -0.25% $-0.24

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$96.11 -0.25% $-0.24

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.99 -0.24% $-0.33

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$282.05 1.69% $4.70

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.97 -0.24% $-0.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.92 2.00% $3.58

Uptrend